Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

NCT02461407 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Anlotinib
DRUG: Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.